newsfilter
← Latest News
GlobeNewswire·

HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences

Gilead purchased 15 million newly issued shares of common stock at a price of $1.4167 per shareFollowing the close of the transaction on December 20, 2023, Gilead holds 19.4% of HOOKIPA's outstanding shares of common